Form D/A — Anavatos Bio Inc.
0002067551-26-000001 · filed Jul 20, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- —
- Reported amount sold
- $392,500
- Minimum investment
- $2,500
- Investors
- 4
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Anavatos Bio Inc.
- CIK
- 2067551
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 2314 NORTH 46TH STREET
SEATTLE, WA 98103 - Phone
- 206 437 3169
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Leah Klein · Executive OfficerSeattle, WA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗